Skip to main content
Clinical Trials/JPRN-jRCTs071200013
JPRN-jRCTs071200013RecruitingPhase 2

Multicenter interventional study of preventive effects of RINDERON-V Ointment 0.12% for severe oral mucositis during radiotherapy for oral cavity and oropharynx tumor

Soutome Sakiko0 sites102 target enrollmentStarted: May 11, 2020Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Enrollment
102

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
>= 20age old to < 90age old (—)
Sex
All

Inclusion Criteria

  • 1. Patients with oral cavity and oropharynx tumor undergoing platinum plus IMRT or cetuximab plus IMRT
  • 2. Conventionally fractionated irradiation with 50Gy or more

Exclusion Criteria

  • 1. Patients with problem in judgement
  • 2. Patients who are allergic to the drugs used
  • 3. Women who are or may be pregnant
  • 4. Oral cavity without the radiation field
  • 5. In the event that the investigator or research investigator determines that participation in this study is not appropriate

Investigators

Sponsor
Soutome Sakiko

Similar Trials